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Myxoma virus is a poxvirus that causes a virulent systemic disease called myxomatosis in European rabbits. Like many
poxviruses, myxoma virus encodes a variety of secreted proteins that subvert the antiviral activities of host cytokines. It was
recently demonstrated that the myxoma virus M-T1 glycoprotein is a member of a large poxvirus family of secreted proteins
that bind CC-chemokines and inhibit their chemoattractant activities in vitro. To determine the biological role of M-T1 in
contributing to myxoma virus virulence, we constructed a recombinant M-T1-deletion mutant virus that was defective in M-T1
expression. Here, we demonstrate that M-T1 is expressed continuously during the course of myxoma virus infection as a
highly stable 43-kDa glycoprotein and is dispensable for virus replication in vitro. Deletion of M-T1 had no significant effects
on disease progression or in the overall mortality rate of infected European rabbits but heightened the localized cellular
inflammation in primary tissue sites during the initial 2 to 3 days of infection. In the absence of M-T1 expression, deep dermal
tissues surrounding the primary site of virus inoculation showed a dramatic increase in infiltrating leukocytes, particularly
monocytes/macrophages, but these phagocytes remained relatively ineffective at clearing virus infection, likely due to the
concerted properties of other secreted myxoma virus proteins. We conclude that M-T1 inhibits the chemotactic signals
required for the influx of monocytes/macrophages during the acute-phase response of myxoma virus infection in vivo, as
predicted by its ability to bind and inhibit CC-chemokines in vitro. © 1999 Academic Press
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It is now evident that viruses use multiple mechanisms
o oppose host defenses to ensure their survival within
n immunocompetent host organism (Kotwal, 1997; Mc-
adden, 1995; Smith, 1994; Spriggs, 1996). Recent inves-
igations have revealed a myriad of proteins expressed
y large DNA viruses that function to evade, block, or
odulate key effector molecules of the innate or ac-
uired arms of the immune system. Such viral strategies
or immune evasion include interference with antigen
resentation, inhibition of apoptosis, blockade of the
omplement cascade, and modulation of the cytokine
etworks (Barry and McFadden, 1998a; McFadden et al.,
998; Ploegh, 1998)
Poxviruses, the largest known DNA viruses, are par-
icularly adept at subverting the host inflammatory re-
ponse by expressing a collective arsenal of proteins
hat alter host cytokines (Alcamı´ et al., 1998b; McFadden,
994; McFadden et al., 1998; Pickup, 1994). Many poxvi-
uses express proteins that bear significant amino acid
imilarity to the extracellular ligand-binding portion of
ellular cytokine receptors. These viral cytokine receptor
imics, or viroceptors, are often secreted glycoproteins
1 To whom reprint requests should be addressed. Fax: (519) 663-
c847. E-mail: mcfadden@rri.on.ca.
233hat function by inhibiting competitively the cytokine li-
ands from binding to their cognate cellular receptors
McFadden, 1995). To date, functional poxviral cytokine
eceptor homologues have been identified for receptors
f tumor necrosis factors (TNFs) (Hu et al., 1994; Loparev
t al., 1998; Schreiber et al., 1996), interferon- (IFN-)a/b
Colamonici et al., 1995; Symons et al., 1995), IFN-g
Mossman et al., 1995a; Upton et al., 1992), and interleu-
in-1b (IL-1b) (Alcamı´ and Smith, 1996; Spriggs et al.,
992).
Myxoma virus, a member of the Leporipoxvirus genus,
auses a highly lethal systemic disease known as myx-
matosis in the European rabbit, Oryctolagus cuniculus
Fenner, 1994; Fenner and Ratcliffe, 1965; McFadden,
988). Given the well-documented natural history and
athogenic profile of myxoma virus and its rabbit host,
yxomatosis provides an excellent model for the study
f virus–host interactions. The pathogenic features of
yxomatosis include extensive hemorrhagic lesions at
he primary site of virus inoculation that is characterized
y tissue degeneration and necrosis. By 7–10 days
ostinfection (p.i.), the virus effectively disseminates
hrough the host lymphoreticular system and induces
umerous internal and external secondary lesions that
ecome visibly evident around the ears, eyelids, lips,
ares, and genitalia. Furthermore, severe dysfunction in
ell-mediated immunity facilitates supervening gram-
0042-6822/99 $30.00
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234 LALANI ET AL.egative bacterial infections of the nasal and conjuncti-
al mucosa and respiratory tract; within 10–14 days,
nfected rabbits invariably experience dyspnea and die
Fenner, 1994; Fenner and Ratcliffe, 1965).
Like all poxviruses, myxoma virus contains a large
;160-kb) double-stranded DNA genome with covalently
losed hairpins and terminal sequences that are inverted
nd repeated (McFadden et al., 1995). Although the cen-
ral portion of most poxvirus genomes are typically con-
erved and encodes for proteins essential for virus rep-
ication and morphogenesis, genes that map toward the
ermini have been shown to be important for determining
irus virulence and host range (Moss, 1996). The deletion
r disruption of these virulence genes usually has no
ffect on virus replication in vitro but can exert a demon-
trable effect on influencing the pathogenic profile within
n infected host. To date, the biological roles of many
istinct myxoma virus genes in contributing to virus vir-
lence in infected laboratory rabbits has been charac-
erized (Barry et al., 1997; Graham et al., 1992; Macen et
l., 1993; Messud-Petit et al., 1998; Mossman et al.,
996a, 1996b; Opgenorth et al., 1992b; Upton et al., 1991).
or example, the M-T2 and M-T7 myxoma gene products
ave previously been shown to be functional soluble
iral cytokine receptors that competitively inhibit the
roinflammatory activities of TNF and IFN-g, respectively
Mossman et al., 1995b; Schreiber et al., 1996). Disrup-
ion of these genes alters pathogenesis and/or markedly
ttenuates the virus, suggesting that these proteins func-
ion in disrupting the host antiviral cytokine circuitry
uring infection (Mossman et al., 1996b; Upton et al.,
991).
The mobilization and activation of immune cells to
ites of viral infection are pivotal components of the early
ost inflammatory response (Nathanson, 1997). Che-
oattractant cytokines, or chemokines, are crucial in
rchestrating this process (Baggiolini, 1998; Luster,
998). Chemokines comprise a large superfamily of
roinflammatory peptides that mediate the activation and
ransmigration of diverse leukocytes by binding to cell
urface seven-transmembrane spanning receptors (Mur-
hy, 1996; Premack and Schall, 1996). The chemokine
uperfamily is further subdivided into four subfamilies (C,
C, CXC, and CX3C) based on structural and functional
haracteristics. Members belonging to the CC-chemo-
ine subfamily are particularly important in the activation
nd recruitment of monocytes, T lymphocytes, dendritic
ells, and natural killer cells during inflammation pro-
esses (Luster, 1998). Given the central role of these
mmune effectors in virus clearance, it is not surprising
hat certain viruses may have adopted mechanisms for
brogating the biological activities of CC-chemokines
Lalani and McFadden, 1997; Murphy and Pease, 1998;
elson and Krensky, 1998; Wells and Schwartz, 1998).
We have recently shown that the first open readingrame (ORF) from the termini of the myxoma virus ge- pome, termed M-T1, encodes a 43-kDa secreted glyco-
rotein that binds to a broad range of CC-chemokines with
igh affinity in a non-species-specific fashion (Graham et
l., 1997; Lalani et al., 1998). Homologous relatives of
-T1 have also been detected in some strains of vac-
inia, rabbitpox, cowpox, ectromelia, raccoonpox, Shope
ibroma, camelpox, and variola (smallpox) viruses (Al-
amı´ et al., 1998a; Graham et al., 1997; Lalani et al., 1998;
mith et al., 1997). This family of related secreted poxvi-
us 35- to 40-kDa glycoproteins is collectively known as
he T1/35kDa family of poxvirus chemokine binding pro-
eins. Although members of the T1/35kDa family show
ariable homology among each another, sequence anal-
ses predict no identifiable relationship to currently
nown cellular proteins, including chemokine receptors
Alcamı´ et al., 1998a; Graham et al., 1997; Smith et al.,
997). Recently, purified M-T1 protein from myxoma virus
as demonstrated to block human CC-chemokines such
s MIP-1a and MCP-1 from binding to their cognate
eceptors with an inhibitory constant (Ki) of ;1.0 nM
Lalani et al., 1998). Moreover, purified M-T1 potently
nhibited chemokine-dependent migration of human
onocytes in vitro (Lalani et al., 1998). In contrast, neither
-T1 nor its homologous 35-kDa counterparts were ca-
able of neutralizing CXC-chemokine activity, indicating
hat the T1/35kDa viral proteins are specific biological
nhibitors for the CC, but not the CXC, subfamily of che-
okines (Alcamı´ et al., 1998a; Lalani et al., 1998; Smith et
l., 1997).
The biological role of one T1/35kDa family member
as previously been studied in a rabbitpox virus (RPV)
odel of pathogenesis (Martinez-Pomares et al., 1995).
PV, a member of the Orthopoxvirus genus, has a
roader host range and has a distinct disease phenotype
o myxoma virus in infected European rabbits. Sequence
omparisons between the RPV-35kDa and myxoma virus
-T1 proteins reveal significant sequence divergence
40% amino acid identity) between the two family mem-
ers (Graham et al., 1997). Mice infected intranasally
ith an RPV 35-kDa null mutant displayed an exacer-
ated illness in comparison to a wild-type RPV virus
nfection, suggesting that this T1/35kDa family member
ay modulate the host inflammatory response in vivo
Martinez-Pomares et al., 1995). Detailed histological
nalyses of RPV-infected rabbit lesions in subsequent
tudies demonstrated that RPV-35kDa alters leukocyte
rafficking significantly during the early phases of RPV
nfection (Graham et al., 1997).
Given the potent in vitro CC-chemokine inhibitory
roperties of the T1/35kDa family members demon-
trated recently, we decided to investigate the biological
ole of the M-T1 glycoprotein during myxoma virus patho-
enesis in the European rabbit. European rabbits were
nfected with a recombinant myxoma M-T1-deletion mu-
ant virus and assessed for differences in pathological
rofiles. Here, we demonstrate that M-T1 markedly influ-
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235MYXOMA VIRUS M-T1 CHEMOKINE INHIBITORY PROTEINnces the chemotaxis of inflammatory cells, particularly
acrophages, into infected tissue sites during the initial
hases of virus infection. However, the increased num-
er of phagocytes are relatively ineffective at clearing the
-T1 deletion mutant virus, suggesting that other myx-
ma viral proteins are able to neutralize the antiviral
ctivities of the infiltrating macrophages.
RESULTS
inetics of M-T1 expression
Previous transcriptional analysis of homologous M-T1
enes in other poxviruses, namely S-T1 of Shope fibroma
irus and 35 kDa of vaccinia virus (strain Lister), have
emonstrated that at least these two members of the
1/35kDa family are transcribed at both early and late
imes (Macaulay et al., 1987; Patel et al., 1990). To deter-
ine the kinetics of M-T1 expression during high multi-
licity (m.o.i. 5 10) myxoma virus infection, we immuno-
lotted myxoma virus-infected cellular supernatants that
ere harvested at various times p.i. As shown in Fig. 1A,
-T1 protein was detected in the medium of infected
ells as early as 2–4 h p.i. and accumulated increasingly
uring the late times of virus replication. By 12 h, .1 3
07 molecules/cell of M-T1 was routinely observed in the
edium of infected cultures (Table 1). An analysis of the
evels of accumulated proteins during infection demon-
trated no significant reduction in the amounts of soluble
-T1 even after 24 h p.i., indicating that the secreted
-T1 polypeptide accumulates as a highly stable ;40- to
5-kDa species (Fig. 1A and Table 1). To determine
hether the mature M-T1 glycoprotein was secreted
ontinuously during the course of infection, infected cell
ultures were washed thoroughly at various times, re-
laced with fresh medium at 4-h intervals, and analyzed
FIG. 1. Immunoblotting analysis of M-T1 secretion from myxoma
irus-infected cells. (A) Accumulation of secreted M-T1 glycoprotein
etected from supernatants of vMyxlac-infected BGMK cells harvested
t various times p.i. (B) Infected cells were washed at 4-h intervals and
eplaced with fresh serum-free medium. Newly synthesized soluble
-T1 in the medium of infected cells during the indicated times p.i. was
etected by Western blotting analysis as outlined in Materials and
ethods.or M-T1 expression throughout the virus replication cy- Mle. Processed M-T1 was observed to be continuously
ecreted from infected cells at comparable rates (;1 3
06 molecules/cell/h) at both early and late times of
nfection with maximal expression (6.67 3 106 mole-
ules/cell) occurring between 4 and 8 h p.i. (Fig. 1B and
able 1). In addition, soluble M-T1 detected at both early
nd late times were equally efficacious at binding CC-
hemokines (data not shown). Thus biologically active
nd significant amounts of soluble M-T1 appear to be
ontinuously secreted through the course of myxoma
irus infection and accumulate in the extracellular envi-
onment as a highly stable 40- to 45-kDa species.
onstruction and analysis of a recombinant
-T1-deletion mutant virus
To determine the biological role of M-T1 in viral viru-
ence, we constructed a recombinant M-T1-deletion mu-
ant myxoma virus, vMyxlacT12, that failed to express
-T1. Because the genomic location of the M-T1 ORF is
ithin the terminal inverted repeats, it is present as
uplicate copies in the myxoma virus genome. Both
opies of the M-T1 ORF were deleted and replaced with
dominant selectable marker gene, Escherichia coli
uanosine phosphoribosyl transferase (Ecogpt), using a
imilar homologous recombination procedure between
he parental virus (vMyxlac) and an engineered transfer
ector as outlined elsewhere (Barry et al., 1997; Macen et
l., 1993; Mossman et al., 1996b). A construct bearing
lanking sequences of M-T1 separated by Ecogpt, pKS-
1KO (Fig. 2 and Materials and Methods), was trans-
ected into vMyxlac-infected cells, and individual foci
urviving three rounds of passage in mycophenolic acid
election were harvested. Plaque-purified viral isolates
ere propagated further and analyzed by PCR and West-
TABLE 1
Quantification of Secreted Myxoma Virus M-T1 Glycoprotein
Time (h p.i.)
Total M-T1 Secreted
mg/106 cells Molecules/cell Molecules/cell/h
umulative
4 0.19 2.70 3 106 0.66 3 106
8 0.65 9.12 3 106 1.14 3 106
12 1.00 1.39 3 107 1.16 3 106
18 1.06 1.48 3 107 0.82 3 106
24 1.40 1.97 3 107 0.82 3 106
ulse-chase
0–4 0.27 3.84 3 106 0.96 3 106
4–8 0.48 6.67 3 106 1.67 3 106
8–12 0.24 3.43 3 106 0.86 3 106
12–18 0.28 3.93 3 106 0.65 3 106
18–24 0.30 4.19 3 106 0.70 3 106
Note. Tabulation of M-T1 levels from infected BGMK cells at various
imes p.i. was determined according to the procedures outlined inaterials and Methods.
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236 LALANI ET AL.rn blotting. As a control, a recombinant M-T1 revertant
irus, vMyxT1R, in which the intact M-T1 ORF was re-
tored fully into its original loci, was constructed using a
imilar genetic approach.
To verify the deletion of M-T1, viral DNA harvested from
laque-purified isolates was subjected to PCR analysis
sing 59 and 39 primers that hybridize to specific M-T1
lanking sequences. Deletion/disruption of M-T1 by
cogpt insertion can be easily visualized by size discrim-
nation of the PCR products under agarose gel electro-
horesis; the presence of any contaminating isolates
earing wild-type M-T1 sequences can also be readily
dentified. As shown in Fig. 3A, although the wild-type
FIG. 2. Construction of a recombinant mutant myxoma virus contain
-T1, pKS-59T1, was generated by restriction digestion of pBS-M-T1 w
mplification using a primer containing an engineered PstI site and clon
igestion with PstI and BamHI and cloned into the complementary si
nsertion of a PstI p7.5Ecogpt cassette was used to form the M-T1 disrup
ith pBS-T1KO DNA, and recombinant viruses (vMyxlacT12) resistan
oward the 59 and 39 flanking sequences of M-T1 (*) were used in PCR-T1 sequence produced an amplified product of ;890 tp (lanes 1 and 3), the integration of Ecogpt within the
isrupted M-T1 sequence yielded a PCR product of
1000 bp (lane 2). In addition to an isolate containing a
ixed pool of both wild-type and vMyxlacT12 recombi-
ants (Fig. 3A, lane 4), one isolate composed of a pure
opulation of vMyxlacT12 recombinants (Fig. 3A, lane 5)
as identified and chosen for further characterization.
CR analysis from a vMyxT1R viral recombinant demon-
trated only the reverted wild-type M-T1 sequence (Fig.
A, lane 6).
To verify whether the vMyxlacT12 recombinant virus
as defective in M-T1 expression, secreted proteins
rom virus-infected cells were analyzed by Western blot-
-T1 disruption. A construct containing a 64-bp 59 coding sequence of
I and BamHI. A 39 terminal fragment of M-T1 was generated by PCR
a pT7Blue T-vector. The 39 M-T1 fragment was isolated after restriction
KS-59T1 to generate the plasmid pKS-T1del. Digestion with PstI and
smid pBS-T1KO. vMyxlac-infected cells were subsequently transfected
gpt selection were harvested and plaque purified. Primers directed
ostic analysis to verify the disruption of M-T1 and insertion of Ecogpt.ing a M
ith Pst
ed into
tes of p
tion pla
t to Ecoing using specific anti-M-T1 antisera. Although the 43-
k
t
(
M
l
3
i
s
u
s
c
d
b
c
M
e
s
p
c
v
p
d
r
(
t
t
c
a
o
l
c
n
a
P
l
a
t
b
b
v
t
s
r
d
w
d
e
d
n
s
F
D
P
3
E
b
v
c
M
a
m
(
a
t
1
1
237MYXOMA VIRUS M-T1 CHEMOKINE INHIBITORY PROTEINDa secreted M-T1 glycoprotein was readily detected in
he supernatants of cells infected with the parental virus
Fig. 3B, lane 2) or vMyxT1R recombinant (Fig. 3B, lane 4),
-T1 was completely absent from the medium of vMyx-
acT12-infected (Fig. 3B, lane 3) or mock-infected (Fig.
B, lane 1) cultures. Similarly, lysates from vMyxlacT12-
nfected cells were devoid of intracellular M-T1 (data not
hown). Furthermore, several other distinct myxoma sol-
ble glycoproteins, namely SERP-1 and M-T7, were ob-
erved to be expressed from vMyxlacT12 and vMyxlac in
omparable amounts, indicating that the deletion of M-T1
id not alter the expression of additional myxoma-solu-
le proteins (data not shown). Taken together, this data
FIG. 3. Characterization of M-T1 from vMyxlac (wild-type), recombi-
ant vMyxlacT12, and vMyxT1R viruses. (A) Agarose gel electrophore-
is of PCR products amplified by flanking M-T1 59 and 39 primers (see
ig. 2). Migration of wild-type M-T1 (lane 1) and M-T1:Ecogpt (lane 2)
NA amplified from pBS-M-T1 and pKS-T1KO plasmids, respectively.
CR analysis of viral DNA harvested from vMyxlac-infected cells (lane
). PCR analysis of viral DNA after homologous recombination and
cogpt dominant selection identified a mixed foci (lane 4) composed of
oth M-T1 and M-T1:Ecogpt and a pure recombinant M-T1-deletion
irus (lane 5) containing only M-T1:Ecogpt. Viral DNA harvested from
ells infected with vMyxT1R demonstrates the presence of wild-type
-T1. Molecular size markers corresponding to BstEII-cut l standards
re shown in lane 7. (B) Western blotting analysis of supernatants from
ock-infected (lane 1), vMyxlac-infected (lane 2), vMyxlacT12-infected
lane 3), and vMyxT1R-infected (lane 4) cells using specific anti-M-T1
ntisera. SDS–PAGE low-molecular-weight markers are indicated to
he right.
T
Pathogenicity of vMyxlac, vMyxT1R, a
Day vMyxlac (wild-type) and vMyxT1R
0 Six NZW rabbits inoculated with 1000 PFU intrade
2–3 Small (0.5–1 cm), slightly inflamed primary lesions
4–7 Large (2–2.5 cm) protuberant demarcated primary
lesions with necrotic centers; few secondary les
mild edema, conjunctivitis, and rhinitis
7–12 Multiple secondary lesions; severe supervening
bacterial infections (mucopurulent discharge of
nares); extreme conjunctivitis, edema, and rhinit
acute dyspnea
0–14 All rabbits sacrificed due to disease severity
4–21onfirm that vMyxlacT12 is a pure recombinant myxoma
-T1 deletion mutant virus that is incapable of M-T1
xpression.
M-T1 is nonessential for replication in vitro. Previous
tudies have demonstrated that virulence factors from
oxviruses are typically nonessential for growth in tissue
ulture. We characterized the growth characteristics of
MyxlacT12 in vitro in several susceptible rabbit and
rimate cell lines. Single-step growth curve analysis
emonstrated no defects in the ability of vMyxlacT12 to
eplicate in cultured primate baby green monkey kidney
BGMK) or rabbit RK-13 fibroblast cells compared with
he parental vMyxlac virus (data not shown). The produc-
ive infection of rabbit lymphocytes is thought to be
rucial for efficient dissemination of the virus via the host
fferent lymphatic channels in vivo. vMyxlacT12 was
bserved to productively infect a rabbit T lymphocyte cell
ine, RL-5, with no observable defects in replication or in
ausing the premature cell death of infected cells (data
ot shown). Thus vMyxlacT12 appears to be dispens-
ble for virus replication in cultured cells in vitro.
athogenesis of vMyxlacT12-infected rabbits
To examine the biological role of M-T1 in virus viru-
ence, European rabbits were infected with vMyxlacT12
nd monitored for any changes in the clinical manifes-
ations of myxomatosis. As summarized in Table 2, rab-
its infected with either the parental vMyxlac or recom-
inant vMyxT1R viruses were indistinguishable and de-
eloped the classic symptoms of myxomatosis, including
he development of fulminating lesions at the primary
ite of inoculation, multiple secondary lesions, blepha-
oconjunctivitis, and supervening bacterial infections. By
ays 10–14, all vMyxlac- and vMyxT1R-infected rabbits
ere sacrificed due to the increased severity of the
isease. Surprisingly, vMyxlacT12-infected rabbits also
xperienced a similar pathogenic profile, including the
evelopment of primary and secondary lesions, oppor-
yxlacT12 Infected European Rabbits
vMyxlacT12
Six NZW rabbits inoculated with 1000 PFU intradermally
Larger (1–2 cm) very inflamed primary lesions; edema
of face and eyes; mild conjunctivitis
Large (2.5 cm) protuberant demarcated primary lesions
with necrotic centers; multiple secondary lesions;
moderate edema, conjunctivitis, and rhinitis
Multiple secondary lesions; severe supervening
bacterial infections (mucopurulent discharge of eyes/
nares); extreme conjunctivitis, edema, and rhinitis;
acute dyspnea; one rabbit with resolving infection
Five of six rabbits sacrificed due to disease severityABLE 2
nd vM
rmally
ions;
eyes/
is;Complete recovery of remaining rabbit
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238 LALANI ET AL.unistic bacterial infections, and five of six (.80%) rabbits
ecame moribund and required euthanasia (Table 2).
owever, one striking phenotypic difference was an aug-
ented inflammation of the primary lesions from the
MyxlacT12-infected rabbits during the early stages of
he disease. By 2–3 days p.i., the primary lesions at the
nitial site of vMyxlac inoculation were barely discernible
Table 2). In contrast, the primary lesions of rabbits in-
ected with the deletion-mutant virus were significantly
arger, displaying heightened inflammation (reddening
nd swelling) and a notable surrounding edematous
one (Table 2). Although the elevated size and inflamma-
ion of the vMyxlacT12 lesions were morphologically
istinct from the vMyxlac lesions between 1 and 3 days
.i., the primary nodules became indistinguishable by 7
ays after infection. In general, the vMyxlacT12-infected
abbits also experienced more edema, conjunctivitis,
nd a slightly accelerated development of bacterial in-
ections, but given the variability of symptomology be-
ween rabbits, we were not able to assess these differ-
nces as significant. Thus the absence of the M-T1 viral
hemokine binding protein resulted in an increased lo-
alized inflammatory response at the primary inoculation
ite during the early phases of the infection but had no
ajor significant effects in attenuating the progression of
isease or on the mortality rate of infected European
abbits.
istological analysis of vMyxlacT12-infected tissues
Gross pathological examinations showed that the pri-
ary vMyxlacT12 tissue lesions exhibited greater in-
lammation and were considerably larger than their wild-
ype infected counterparts during the first 3 days of
nfection. Given these notable differences in the early
nflammatory response at the primary site, tissue sam-
les were resected at 2, 3, and 7 days p.i. for complete
istological analysis. Microscopically, the epidermis of
he vMyxlacT12 primary sites showed more reactivity
nd hyperplasia than vMyxlac tissues, indicative of an
ntense inflammatory response occurring at 2–3 days p.i.
data not shown). Stained tissue sections revealed strik-
ng differences in cellular infiltrates within the deep der-
is of the primary lesions between the two sets of
abbits (Fig. 4). By 2 and 3 days p.i., a mild focal inflam-
atory response with a sparse number of infiltrating
eukocytes was observed in the dermal tissues of vMyx-
ac primary sites (Figs. 4, A and C). In contrast, a intense
idespread inflammatory reaction with a marked in-
rease in heterophil and mononuclear rabbit leukocytes
as observed in the deep dermal layer of vMyxlacT12
rimary tissues (Figs. 4, B and D). To determine whether
-T1 was modulating the influx of leukocytes within
nfected tissues, rabbit leukocytes permeating the der-
al tissues were enumerated. In the absence of M-T1xpression, we observed an approximate threefold to dourfold increase in the number of leukocytes migrating
eeply into the primary tissues (Fig. 5A), suggesting that
-T1 alters the trafficking of inflammatory cells in vivo
uring the early phases of myxoma virus infection.
-T1 blocks monocyte/macrophage influx in vivo
We previously demonstrated that M-T1 potently inhib-
ts CC-chemokines from inducing the chemotactic migra-
ion of primary monocytes in vitro (Lalani et al., 1998). We
redicted, therefore, that M-T1 may also abrogate CC-
hemokine-mediated migration of inflammatory effectors
elonging to the monocyte/macrophage cell lineage dur-
ng virus infection in vivo. The discrimination of rabbit
eukocyte subclasses by surface marker expression is
oorly defined, and few reagents currently exist for op-
imal immunohistochemical analysis of rabbit tissues. To
haracterize the effects of M-T1 on monocytic influx dur-
ng myxoma virus infection, tissue sections were immu-
ostained with RAM11, a murine monoclonal antibody
hat is specific to rabbit monocytes/macrophages (Lucas
t al., 1996; Tsukada et al., 1986). As shown in Fig. 5B,
here was a significant elevation in the percentage of
nfiltrating rabbit monocytes/macrophages into the der-
al tissues early (2–3 days) during vMyxlacT12 infec-
ion. We were unable to accurately assess the differ-
nces in RAM11-positive leukocytes in the day-7 tissues
ue to widespread tissue necrosis or determine which
dditional leukocyte subpopulations may have altered
igration patterns by vMyxlacT12. Nevertheless, our
ata suggest that the expression of the M-T1 glycopro-
ein has profound effects on influencing the effective
igration of rabbit inflammatory leukocytes, such as
onocytes/macrophages, during viral infection in vivo,
onsistent with the biochemical property of M-T1 as a
otent CC-chemokine inhibitor in vitro.
iral burden in infected lesions
Macrophages play a central role in the early response
o virus infection by facilitating intrinsic resistance mech-
nisms and generating secreted antiviral cytokines
Nathanson, 1997). Because myxoma virus expresses a
ariety of proteins that target host inflammatory cells, we
xamined tissues from primary lesions to determine
hether the increased level of macrophages observed
uring vMyxlacT12 infection had any effects on virus
learance. Because the parental vMyxlac and mutant
MyxlacT12 viruses both express an E. coli lacZ trans-
ene, localization of either virus within infected tissues
an be readily identified by staining sections with an
ntibody against b-galactosidase. No significant qualita-
ive differences in the level of b-galactosidase staining,
s a marker for viral gene expression, were observed in
he primary or secondary dermal tissues from vMyxlac-
r vMyxlacT12-infected rabbits at 3 days (Fig. 6) or 7
ays (data not shown) p.i. Thus although the increased
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239MYXOMA VIRUS M-T1 CHEMOKINE INHIBITORY PROTEINumber of infiltrating phagocytes were present in vMyx-
acT12-infected primary tissues at 3 days p.i., the viral
urdens of both the mutant and the wild-type myxoma
iruses remain at comparable levels. We conclude that
espite the increased levels of infiltrating macrophages
n lesions infected with vMyxlacT12 virus, the effective
ntiviral activities of these responding phagocytes were
ikely compromised by the summated activities of other
nti-inflammatory myxoma viral proteins.
DISCUSSION
A major strategy used by poxviruses in thwarting the
ost-inflammatory response to virus infection involves
he sequestration of crucial host biological response
odifiers such as key cytokines critical for orchestrating
he antiviral responses (Alcamı´ et al., 1998b; Barry and
cFadden, 1998b; Spriggs, 1996). A growing number of
ecreted poxvirus glycoproteins, including vIFN-a/b re-
FIG. 4. Histological analysis of primary lesion tissues. Microscopic a
he primary site of inoculation with vMyxlac (A and C) or vMyxlacT12eptors, vIFN-g receptors, vIL-1b receptors, and vTNF feceptors, have been identified with activities aimed at
isrupting host cytokine networks (McFadden et al.,
995). In addition to being capable of effectively neutral-
zing the antiviral activities of their respective cytokines
n vitro, many of these viroceptors have been shown to
unction as anti-inflammatory virulence factors because
heir deletion alters the pathogenesis of their infected
osts in vivo (McFadden et al., 1998).
The coordinated recruitment of immune cells to sites
f virus infection is a key feature of the early host inflam-
atory response to pathogenic insult (Nathanson, 1997).
hemokines are believed to be critical in this process by
electively activating and mobilizing monocytes, T lym-
hocytes, dendritic cells, natural killer cells, and granu-
ocytes to sites of infection and damage (Luster, 1998).
s a consequence of the important roles that chemo-
ines play in orchestrating inflammatory processes, cer-
ain viruses have devised a number of countermeasures
s (magnification 4003) of the deep dermal layer of rabbit tissues from
D) harvested at 2 days (A and B) and 3 days (C and D) p.i.nalyseor neutralizing the activities of chemokines or their re-
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240 LALANI ET AL.eptors (Lalani and McFadden, 1997; Murphy and Pease,
998; Nelson and Krensky, 1998; Wells and Schwartz,
998). There are three strategies of chemokine subver-
ion known to be used by viruses: (1) virus-encoded
hemokine ligand homologues that function as antago-
ists, (2) virus-encoded cell-surface chemokine receptor
omologues, and (3) virus-encoded secreted chemokine
inding proteins such as the myxoma virus M-T1 glyco-
rotein. However, the significance of many of these viral
roteins in contributing to viral pathogenesis or in abro-
ating the activities of chemokines in vivo has not been
ully addressed.
We have previously shown that the myxoma virus M-T1
lycoprotein binds to a broad spectrum of CC-chemo-
ines with high affinity and effectively sequesters soluble
hemokine ligands from engaging their cell-surface re-
FIG. 5. M-T1 blocks leukocyte infiltration in virus-infected tissues. (A)
nfiltrating rabbit leukocytes within the deep dermal layer of tissues
rom vMyxlac (open bars) and vMyxlacT12 (filled bars) primary lesions
ere enumerated in three high-power fields from hematoxylin and
osin-sectioned tissues as outlined in Materials and Methods. (B)
rimary tissues from vMyxlac (open bars) and vMyxlacT12 (filled bars)-
nfected rabbits were harvested at 2 and 3 days p.i. and stained with
AM11 antibody. Peroxidase-stained RAM111 monocytes/macro-
hages in the deep dermis of infected tissues were counted in three
andom high-power fields, and the results are expressed as the per-
entage of infiltrating RAM111 macrophages/total infiltrating rabbit
eukocytes within virus-infected tissues.eptors (Graham et al., 1997; Lalani et al., 1998). In mddition, using in vitro chemotaxis assays, M-T1 was
hown to be capable of blocking MIP-1a and MCP-1 from
timulating the unidirectional migration of primary hu-
an monocytes, suggesting that M-T1 may play a fun-
amental biological role in myxoma virus pathogenesis
y functionally retarding the proper trafficking of rabbit
hagocytes in vivo (Lalani et al., 1998). Here we demon-
trate that the expression of M-T1 during myxoma virus
nfection in vivo results in marked perturbations of the
xtent and amount of leukocyte infiltration into virus-
nfected tissues, although these additional phagocytes
xert only minimal effects on virus-induced mortality
ates.
Our present study demonstrates that the myxoma
-T1 glycoprotein is secreted continuously during early
nd late times of virus infection and is nonessential for
irus replication in vitro. Given the potent CC-chemokine
nhibitory properties of M-T1 previously displayed in vitro,
e were surprised to discover that the deletion of M-T1
rom myxoma virus does not significantly reduce the
ethality of the myxomatosis disease progression in in-
ected European rabbits. Rather, M-T1 was shown to
ave demonstrable alterations in localized inflammation
urrounding the primary sites of infection, but the in-
reased numbers of infiltrating phagocytes were still
elatively ineffective at virus clearance. Rabbits infected
ith an M-T1-null mutant experienced a notable eleva-
ion of inflammation at the primary lesions in comparison
o an infection with the parental virus during the early
hases of infection. The heightened inflammatory re-
ponse observed during gross examinations of vMyx-
acT12-infected rabbits was also confirmed by histolog-
cal analysis. The deletion of M-T1 resulted in an in-
rease in the extravasation of rabbit monocytes/
acrophages, and perhaps additional leukocytes, into
nfected dermal tissues. Thus M-T1 appears to play a
ignificant role in altering the directional migratory sig-
als that are required for influx of inflammatory cells
uring the acute-phase response to myxoma virus infec-
ion as predicted by the in vitro activities of all the
1/35kDa family members as potent CC-chemokine in-
ibitors (Alcamı´ et al., 1998a; Lalani et al., 1998; Smith et
l., 1997).
Our results are in agreement with prior investigations
f a distinct M-T1 family member, namely RPV-35kDa, in
rabbitpox virus model of pathogenesis (Martinez-Po-
ares et al., 1995). The deletion of 35-kDa ORF from RPV
esulted in a modest acceleration of illness in infected
alb/c mice and no overall difference in the pathogene-
is of infected European rabbits (Martinez-Pomares et
l., 1995). However, histological analysis in subsequent
tudies revealed dramatic alterations of lymphocyte che-
otaxis in primary rabbit tissues during early phases of
nfection (Graham et al., 1997). Another example of the
ifficulty of using morbidity as an end-point measure-
ent for poxvirus virulence is the case of deleting the
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241MYXOMA VIRUS M-T1 CHEMOKINE INHIBITORY PROTEINIL-1b receptor of vaccinia virus, which resulted in an
ccelerated pathogenicity and morbidity after intranasal
noculation but attentuation after intracerebral injection
Alcamı´ and Smith, 1992; Spriggs et al., 1992). Thus it has
een proposed that certain viroceptors may play a role in
rotecting the host from the detrimental effects caused
FIG. 6. Viral load in infected primary dermal tissues. Primary tissue s
t 3 days p.i. and subjected to immunoperoxidase staining with an anti
taining of b-galactosidase correlates with the presence of vMyxlac or
arker.y the excessive production of certain cytokines in re- iponse to infection (Alcamı´ and Smith, 1995). In this
espect, it is entirely plausible that M-T1 may function in
oderating the level of the host acute-phase response to
acilitate viral replication and spread during the early
hases of myxoma virus infection.
The elevated levels of infiltrating phagocytes observed
from vMyxlac (A) and vMyxlacT12 (B)-infected rabbits were harvested
ctosidase antibody as outlined in Materials and Methods. Peroxidase
T12 within infected tissues because both viruses encode a lacZ geneections
-b-gala
vMyxlacn vMyxlacT12 tissues did not appear to be sufficient to
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242 LALANI ET AL.esolve virus infection because the detectable viral bur-
en was essentially identical between vMyxlac- and
MyxlacT12-infected tissues. It is entirely plausible that
he infiltrating phagocytes during vMyxlacT12 infection
emain poorly activated and unable to clear virus infec-
ion and that at least one of the other known secreted
yxoma virulence factors, SERP-1, functions by directly
nhibiting inflammatory cells (Lucas et al., 1996; Macen et
l., 1993). Thus although M-T1 may effectively suppress
he chemoattraction of inflammatory effector cells early
uring the course of infection, the consolidated activities
f additional myxoma virus factors likely contribute to
reventing these increased numbers of phagocytes from
locking the development of full-scale myxomatosis
athogenesis.
In addition to M-T1, myxoma virus expresses a second
istinct soluble glycoprotein, M-T7, which has been dem-
nstrated to bind chemokines in vitro and influence leu-
ocyte influx during myxoma virus infection (Lalani et al.,
997; Mossman et al., 1996b). However, unlike M-T1,
hich prevents chemokine–receptor interactions, M-T7
as been postulated to function in a distinct manner by
isrupting the establishment of solid-phase chemokine
radients along the extracellular matrix (Lalani et al.,
997; Lalani and McFadden, 1997). In addition, M-T1
odulates cellular influx significantly earlier than the
nhibition of infiltration observed previously with M-T7
Mossman et al., 1996b), suggesting that these proteins
re functionally nonredundant during myxoma virus in-
ection.
MATERIALS AND METHODS
ells and viruses
vMyxlac, a myxoma virus (strain Lausanne) derivative
earing a b-galactosidase marker cassette in an inter-
enic location, was used as the parental wild-type strain
n this study and has been described previously
Opgenorth et al., 1992a). The constructions of both re-
ombinant myxoma M-T1-deletion mutant (vMyxlacT12)
nd revertant (vMyxT1R) viruses are described below. All
iruses were propagated in African BGMK cells (Ameri-
an Type Culture Collection). BGMK cells were pas-
aged in DMEM supplemented with 10% newborn calf
erum (GIBCO BRL), 100 units/ml penicillin (BioWhittaker
nc.), 100 mg/ml streptomycin (BioWhittaker Inc.), and 2
M glutamine (BioWhittaker Inc.). RK-13 cells, a rabbit
idney cell line (American Type Culture Collection), was
aintained under similar conditions.
onstruction of recombinant vMyxlacT12 and
MyxT1R viruses
To create the myxoma M-T1-deletion mutant virus,
MyxlacT12, both copies of the M-T1 ORF were deleted/
isrupted by insertion with a dominant selectable marker Bs shown by the schematic in Fig. 2. A pBluescript vector
ontaining the entire M-T1 gene, pBS-M-T1 (Graham et
l., 1997), was restriction digested with PstI and BamHI
o remove a majority of the M-T1 coding sequence cre-
ting the vector pKS-59T1. A fragment containing a small
9 flanking portion of M-T1 was amplified from pBS-M-T1
y PCR using a 39 M-T1 primer containing an engineered
stI site, T1–39Pst (CTACCCTGCAGGCGTGTAAC), and a
orward primer corresponding to a downstream vector
equence. The amplified products were cloned into a
T7Blue T-vector (Novagen), and a 192-bp PstI–BamHI
ragment was excised and ligated into pKS-59T1, creating
he plasmid pKS-T1del. In addition to flanking se-
uences, the construct contained the 59 64-bp and 39
0-bp coding sequences of M-T1 separated by an inter-
al PstI site. A PstI cassette containing the Ecogpt gene,
hose expression is driven by the vaccinia 7.5K pro-
oter (Falkner and Moss, 1988), was inserted into pKS-
1del, creating pKS-T1KO.
vMyxlacT12 virus was generated by homologous re-
ombination with the pKS-T1KO plasmid with a vMyxlac
nfection/transfection procedure using mycophenolic
cid selection (Falkner and Moss, 1988) as previously
escribed (Mossman et al., 1996a, 1996b). To verify the
isruption of M-T1 and insertion of the Ecogpt cassette,
rimers flanking the 59 (59T1-ATAGAAGGATCCTATCAT-
AAAC) and 39 (39T1-CGACATGGATCCTAGATAGGATTA)
equences of M-T1 were generated, and PCR analysis
as performed. vMyxlacT12 was subsequently used
long with the plasmid pBS-M-T1 to create a myxoma
-T1 revertant virus, vMyxT1R, in which the intact M-T1
ene was restored fully into its original loci by a similar
rocedure described elsewhere (Macen et al., 1996;
ossman et al., 1996a).
mmunoblotting analysis
Soluble M-T1 was detected from virus-infected cellular
upernatants using Western blotting analysis as de-
cribed previously (Lalani et al., 1998). Briefly, BGMK
ells were infected with vMyxlac, vMyxlacT12, or
MyxT1R at an m.o.i. of 10. After 1 h, cells were washed
horoughly with PBS to remove unabsorbed virus and
ultured overnight (or for various times as indicated) with
resh serum-free media. Supernatants were then har-
ested, clarified of virus and cellular debris, and concen-
rated 10-fold using spin microconcentrators (Millipore).
oncentrated supernatants were resolved by 12% SDS–
AGE and transferred to HyBond-C supported nitrocellu-
ose (Amersham Inc.) using a semidry transfer apparatus
Tyler Corp.) for 1 h at 50 mA. Membranes were blocked
vernight in Tris-buffered saline (TBS) containing 5%
kim milk powder and 0.2% Tween 20 (ICN Biomedicals
nc.), and then probed with (1:5000 dilution) polyclonal
nti-M-T1 peptide antisera (Lalani et al., 1998) for 1 h.
lots were washed with TBS-0.2% Tween 20, reprobed
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243MYXOMA VIRUS M-T1 CHEMOKINE INHIBITORY PROTEINith (1:500 dilution) horseradish peroxidase-conjugated
oat anti-rabbit IgG secondary antibody (Jackson Labo-
atories), and subsequently visualized by enhanced
hemiluminescence (NEN Life Sciences).
uantification of secreted M-T1 from infected cells
Supernatants containing myxoma virus secreted pro-
eins were harvested at various times p.i. and immuno-
lotted according to a similar procedure as that de-
cribed. To calculate the amount of soluble M-T1 pro-
uced during myxoma virus infection, chemiluminescent
-T1 bands were detected using an FX Molecular Imag-
ng System (Bio-Rad) and quantified using purified M-T1
rotein standards.
ingle-step growth curve analysis
Six-well multidishes containing 5 3 105 BGMK or
K-13 cells were infected with vMyxlac or vMyxlacT12 at
n m.o.i. of 5 for 1 h at 37°C. After viral absorption, the
ells were washed three times with PBS and incubated
ith DMEM-containing serum. Infected cultures were
arvested at 0, 4, 8, 24, and 48 h p.i., and viral titers were
etermined on BGMK cells as described previously
Mossman et al., 1996a). All infections were performed in
riplicate, and results are expressed as the average viral
iters (log PFU/105 cells) 6 S.D.
athogenesis of virus-infected rabbits
Adult female New Zealand White rabbits (Oryctolagus
uniculus) were purchased from a local supplier and
oused within a biohazard level 3 containment facility in
ompliance with guidelines of the Canadian Council on
nimal Care. Rabbits were injected intradermally with
000 PFU of virus below each thigh. Virus titers were
erified before experimentation to ensure the accuracy of
he dose inoculum. For gross pathological studies, six
abbits were inoculated with vMyxlacT12 (M-T1-deletion
utant virus); three rabbits with vMyxlac (parental wild-
ype strain); and three rabbits with vMyxT1R (recombi-
ant M-T1 revertant virus). The infected rabbits were
bserved daily for clinical symptoms of myxomatosis,
nd any rabbits that appeared moribund were promptly
uthanized with an intravenous overdose of pentobarbi-
al. For histological studies, six rabbits were each inoc-
lated with vMyxlac or vMyxlacT12 as described above.
wo rabbits from each group were sacrificed at 48 h,
2 h, and 7 days p.i. and subjected to a complete post-
ortem examination. Tissue sections were harvested
fter necropsy and stored in neutral-buffered 10% forma-
in before histological analysis (discussed below).
mmunohistological analysis
Infected rabbit tissue samples were paraffin embed-
ed, and 5-mm sections were stained with hematoxylinnd eosin for microscopic analysis. To determine spe-
ific infiltrating leukocyte subpopulations within infected
esions, sections were further analyzed by immunohisto-
hemical staining as described elsewhere (Mossman et
l., 1996b). To detect rabbit monocyte/macrophages in-
iltrates, samples were stained with a rabbit macro-
hage-specific monoclonal antibody, RAM11 (a kind gift
rom Dr. E. Raines, University of Washington), at a dilution
f 1:500 (Tsukada et al., 1986). Positive-stained (RAM11)
abbit monocytes/macrophages were enumerated from
wo independent sets of blinded rabbit sections per time
oint by microscopy using three random high-power
ields, and the results are expressed as the percentage
f infiltrating RAM111 macrophages/total number of leu-
ocytes/field in the deep dermal tissue. To evaluate the
resence of the virus within infected tissues, samples
ere immunostained with (1:500 dilution) anti-b-galacto-
idase antibody (Promega) to detect the presence of the
. coli lacZ gene product expressed from vMyxlac and
MyxlacT12 (Mossman et al., 1996b).
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